Harnessing the structural plethora of peptides to discover novel therapeutics.
3B Pharmaceuticals GmbH (3BP), a private German biotechnology company today announced a multi-year collaboration in the field of peptide-led drug discovery with…
Apply for individual support to enter the Japanese or Korean life science market successfully
Bayer’s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival with a favorable
safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer
inDemand is a new model where Healthcare organizations and companies co-create Digital Health solutions, with the economic support of public regional funds. This EU project is currently being developing in three pilot regions: Murcia (Spain), Paris…
W&W brandpool Joins Kinderheldin’s Investor Base
American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) 2019
Asahi Kasei Pharma to Solicit Proposals for Drug Discovery Research
Asahi Kasei Pharma is publicly calling for new proposals related to drug development research as part its efforts for open innovation, to promote pharmaceutical research and…
Shifting from treating symptoms to curing diseases and making Europe the world leader in Advanced Therapies is the aspiration of RESTORE – the Large-Scale Research Initiative, led by Charité. On February 8, the European Commission (EC) backed that…
Adrenomed AG, the vascular integrity company, today announced that the Phase II clinical trial design of AdrenOSS-II was published by the peer-reviewed open access journal BMJ Open. The currently ongoing Phase II trial is conducted to assess the…
